Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Submacular surgery. Are randomized trials necessary?

× No keyword cloud information.

6 in total

Review 1. Treatment of subfoveal choroidal neovascularisation in age related macular degeneration: focus on clinical application of verteporfin photodynamic therapy.

Authors: G Soubrane; N M Bressler
Journal: Br J Ophthalmol Date: 2001-04 Impact factor: 4.638

2. Clinical trial performance of community- vs university-based practices in the submacular surgery trials (SST): SST report no. 2.

Authors: Neil M Bressler; Barbara S Hawkins; Susan B Bressler; Päivi H Miskala; Marta J Marsh
Journal: Arch Ophthalmol Date: 2004-06

3. Surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: ophthalmic findings: SST report no. 13.

Authors: Neil M Bressler; Susan B Bressler; Ashley L Childs; Julia A Haller; Barbara S Hawkins; Hilel Lewis; Mathew W MacCumber; Marta J Marsh; Maryann Redford; Paul Sternberg; Matthew A Thomas; George A Williams
Journal: Ophthalmology Date: 2004-11 Impact factor: 12.079

Review 4. Age-related macular degeneration: cost-of-illness issues.

Authors: C Oneill; J Jamison; D McCulloch; D Smith
Journal: Drugs Aging Date: 2001 Impact factor: 3.923

5. Responsiveness of the National Eye Institute Visual Function Questionnaire to changes in visual acuity: findings in patients with subfoveal choroidal neovascularization--SST Report No. 1.

Authors: Päivi H Miskala; Barbara S Hawkins; Carol M Mangione; Eric B Bass; Neil M Bressler; Li Ming Dong; Marta J Marsh; Lee D McCaffrey
Journal: Arch Ophthalmol Date: 2003-04

6. An analysis of ranibizumab treatment and visual outcomes in real-world settings: the UNCOVER study.

Authors: Bora Eldem; Timothy Y Y Lai; Nor Fariza Ngah; Brendan Vote; Hyeong Gon Yu; Alban Fabre; Arthur Backer; Nathan J Clunas
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2018-03-03 Impact factor: 3.117

6 in total